Opportunity Analysis For Celiac Disease till 2023

1
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to
2023 By RnRMarketResearch

• Browse more reports on Pharmaceuticals at
  http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
2
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to 2023

• There are no pharmacological treatments that are
  indicated for celiac disease and the current
  standard of care treatment involves a gluten free
  diet (GFD). Steroids and immuno suppressants are
  used to reduce symptoms in severe cases,
  targeting approximately 5 of the celiac disease
  patient population and there are no preventative
  medications. The anticipated launch of
  Alba/Tevas larazotide acetate in 2018 in the US
  and 2019 in 5EU, followed by the launch of
  Alvine/AbbVies latiglutenase in 2019 and 2020 in
  the US and 5EU respectively are set to change the
  management of the disease and drive growth in the
  celiac disease market.
• Complete report available at http//www.rnrmarketr
  esearch.com/opportunityanalyzer-celiac-disease-opp
  ortunity-analysis-and-forecast-to-2023-market-repo
  rt.html .

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
3
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to 2023

• Key Questions Answered-
• How will the celiac disease market landscape
  change within the 2013-2018 and the 2013-2023
  forecast periods in the 6MM?
• What are the most promising late-stage pipeline
  drugs and how will their launch shape the future
  treatment landscape in the celiac disease market?
• How do the clinical and commercial attributes of
  late-stage pipeline drugs compare to one another
  and against existing treatment options?
• What are the significant unmet needs in the
  celiac disease market?

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
4
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to 2023

• Scope
• Overview of celiac disease, including
  epidemiology, etiology, pathophysiology, symptoms
  and current treatment options
• Annualized celiac disease therapeutics market
  revenue, annual cost of therapies and forecasts
  for five years to 2018 and ten years to 2023.
• Key topics covered include strategic product
  assessment, market characterization, unmet needs,
  RD strategies, clinical trial design and
  implications for the celiac disease therapeutics
  market.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
5
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to 2023

• Reasons to Buy
• Identify the unmet needs and remaining
  opportunities in the celiac disease therapeutics
  market.
• Develop business strategies by understanding the
  trends shaping and driving the US and five major
  EU celiac disease therapeutics market.
• Identify emerging players with potentially strong
  product portfolios and create effective
  counter-strategies to gain a competitive
  advantage.
• Assess the clinical and commercial viability of
  promising pipeline products.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441
6
Opportunity Analyzer Celiac Disease
Opportunity Analysis and Forecast to 2023

• For more details contact Mr. Ritesh Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnRMarkertResearch RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR Market Research library has
syndicated reports by leading market research 
publishers across the globe.

http//www.rnrmarketresearch.com/
sales_at_RnRMarketResearch.com 1 888 391 5441